Shanghai Institute of Materia Medica Chinese Academy of Sciences:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Shanghai Institute of Materia Medica Chinese Academy of Sciences - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9316
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Institute of Materia Medica Chinese Academy of Sciences (SIMM) is an educational research institute that provides research and development of traditional Chinese medicine. The institute offers solutions in the areas of drug discovery and drug development. It also offers studies of structure-activity relationships of bioactive substances, new chemical entities, pre-clinical evaluation and pharmaceutical development. SIMM develops drugs such as artemether, dimercaptosuccinic acid, and huperzine a, depsides salts, antofloxacin hydrochloride, and others. The institute carries out research in the areas of drug screening, pharmacology, medicinal chemistry, products chemistry, combinatorial chemistry, toxicology, pharmacokinetics and computer-aided drug design, among others. SIMM is headquartered in Pudong, China.

Shanghai Institute of Materia Medica Chinese Academy of Sciences – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Shandong Luoxin Pharma Enters into Agreement with Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Fudan University 10
TechnoPhage Enters into Co-Development Agreement with Shanghai Institute of Materia Medica 11
Shanghai Fosun Pharma Enters Into Co-Development Agreement With Shanghai Institute of Materia Medica To Develop Cancer Drug 12
Licensing Agreements 13
Servier Enters Into Licensing Agreement With Shanghai Institute Of Materia Medica 13
Asset Transactions 14
3SBio Acquires Patents For DJ5, Potential Renal Failure Therapy, From SIMM 14
Shanghai Institute of Materia Medica Chinese Academy of Sciences – Key Competitors 16
Shanghai Institute of Materia Medica Chinese Academy of Sciences – Key Employees 17
Shanghai Institute of Materia Medica Chinese Academy of Sciences – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Government and Public Interest 19
Jun 22, 2018: Scientists Make a Major Breakthrough in Signal Transduction of GPCR 19
Product News 20
Aug 30, 2018: Biomimetic strategy realizes imaging-guided treatment of Breast Cancer Metastasis 20
Jan 03, 2018: Glucagon Receptor Structure Offers New Opportunities for Type 2 Diabetes Drug Discovery 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Key Facts 2
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Shandong Luoxin Pharma Enters into Agreement with Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Fudan University 10
TechnoPhage Enters into Co-Development Agreement with Shanghai Institute of Materia Medica 11
Shanghai Fosun Pharma Enters Into Co-Development Agreement With Shanghai Institute of Materia Medica To Develop Cancer Drug 12
Servier Enters Into Licensing Agreement With Shanghai Institute Of Materia Medica 13
3SBio Acquires Patents For DJ5, Potential Renal Failure Therapy, From SIMM 14
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Key Competitors 16
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Key Employees 17

List of Figures
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Shanghai Institute of Materia Medica Chinese Academy of Sciences:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • FedEx Corporation (FDX):企業の財務・戦略的SWOT分析
    FedEx Corporation (FDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Chembond Chemicals Ltd (530871):企業の財務・戦略的SWOT分析
    Chembond Chemicals Ltd (530871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • ReWalk Robotics Ltd (RWLK):企業の財務・戦略的SWOT分析
    Summary ReWalk Robotics Ltd (ReWalk) is a medical device company that designs, develops and commercializes exoskeletons. The company offers walk restoration devices for people with lower limb disabilities to stand and walk once again. Its products include ReWalk personal system and ReWalk rehabilita …
  • Ventana Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ventana Medical Systems Inc (VMS), a subsidiary of F. Hoffmann-La Roche Ltd is a manufacturer of tissue-based diagnostic solutions for healthcare market. The company develops cancer diagnostic solutions for breast pathology, cervical diagnostics, colorectal pathology, special stains, lung pa …
  • Energinet.dk:企業の戦略的SWOT分析
    Energinet.dk - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • LM Wind Power Holding AS:企業の戦略的SWOT分析
    LM Wind Power Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • MedNet Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary MedNet Solutions Inc (MedNet Solutions) is a healthcare technology company which provides eClinical and electronic data capture software solutions. The company developed iMedNet, an eClinical technology platform which provides non – technical clinical research for clinical trials or studies. …
  • Brodrene Hartmann A/S:企業の戦略・SWOT・財務情報
    Brodrene Hartmann A/S - Strategy, SWOT and Corporate Finance Report Summary Brodrene Hartmann A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • GP Strategies Corp (GPX):企業の財務・戦略的SWOT分析
    Summary GP Strategies Corp (GP Strategies) is a performance improvement company that offers sales and technical training, eLearning solutions, management consulting, and engineering services. The company offers solutions such as human capital management, managed learning services, off the shelf offe …
  • MemorialCare Health System-製薬・医療分野:企業M&A・提携分析
    Summary MemorialCare Health System (MemorialCare) is a nonprofit health system that offers medical services. The center offers care services such as stroke care, cancer care, rehabilitation and physical therapy, weight-loss surgery, heart and vascular care, breast care, imaging and radiology, labora …
  • Northwest Biotherapeutics Inc (NWBO)-医療機器分野:企業M&A・提携分析
    Summary Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer in an effective way without toxicities associated with the normal chemotherapy drugs. The company by utilizing its proprietary technology plat …
  • AutoCanada Inc.:企業のM&A・事業提携・投資動向
    AutoCanada Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AutoCanada Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Tikcro Technologies Ltd (TIKRF):企業の財務・戦略的SWOT分析
    Summary Tikcro Technologies Ltd (Tikcro) is a biotechnology company that discovers, develops, manufactures and markets antibodies. The company undertakes clinical trials for its pipeline products PD1, PDL1, PDL2, TIGIT and CTLA-4 products, among others. Its products are based on 3D antigens designed …
  • Billabong International Limited:企業のM&A・事業提携・投資動向
    Billabong International Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Billabong International Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • HOV Services Ltd (HOVS):企業の財務・戦略的SWOT分析
    HOV Services Ltd (HOVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Olin Corporation:企業の戦略・SWOT・財務分析
    Olin Corporation - Strategy, SWOT and Corporate Finance Report Summary Olin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Goldin Financial Holdings Ltd:企業の戦略・SWOT・財務情報
    Goldin Financial Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Goldin Financial Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Grain Processing Corp:企業の戦略的SWOT分析
    Grain Processing Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Berjaya Corporation Berhad (BJCORP):企業の財務・戦略的SWOT分析
    Berjaya Corporation Berhad (BJCORP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Uflex Limited:企業の戦略・SWOT・財務情報
    Uflex Limited - Strategy, SWOT and Corporate Finance Report Summary Uflex Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆